ArticleBiomolecules & therapeutics2023

Inhibition of DNMT3B and PI3K/AKT/mTOR and ERK Pathways as a Novel Mechanism of Volasertib on Hypomethylating Agent-Resistant Cells.

Eun-Ji Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.